Exxon and Chevron decline new spending in Venezuela while taking a wait-and-see approach for the years ahead

Exxon Mobil and Chevron said Jan. 30 they will not increase capital spending in Venezuela this year while awaiting legal and political reforms, with Exxon planning only a small technical team visit and Chevron relying on self-funded joint ventures with PDVSA under a special license. Chevron currently produces nearly 250,000 b/d in Venezuela (about a quarter of the country’s ~1 million b/d) and says it could lift flows by 50% within two years, but both CEOs cited the need for fiscal stability and attractive terms before committing more capital. Both companies reported lower profits on the quarter and year: Exxon Q4 earnings $6.5bn (-15% YoY) and full-year $28.8bn (-14% YoY), Chevron Q4 ≈$2.8bn (down ~15% YoY) and full-year $12.3bn (-30% YoY); executives flagged geopolitical, regulatory and price challenges that keep Venezuelan investments contingent on reforms.

Analysis

Market structure: Chevron (CVX) is the clear near-term winner — its special license and ~250k b/d production gives it optionality to add ~125k b/d within two years, a ~50% lift to its Venezuelan output but only ~0.1–0.2% of global demand, so oil-price impact will be muted. Exxon (XOM) is the political and execution loser short-term; its Venezuela assets remain stranded until fiscal/regulatory clarity and US policy risk decline. Service contractors with heavy-oil expertise (e.g., sand/oil-sands tech suppliers) are long-term beneficiaries if reforms proceed.

Risk assessment: Tail risks include renewed US sanctions or asset expropriation (low probability, high impact), an adverse ICJ decision on Guyana/Venezuela (6–12 month horizon), or PDVSA operational failure that converts JV cash-flow self-funding into losses. Immediate (days) risk: earnings-driven volatility; short-term (weeks–months): Venezuelan hydrocarbons law and US policy signals; long-term (years): multi-billion-dollar capex decisions and ramp timing. Hidden dependency: Chevron’s ability to expand is funded by JV cash flows — a PDVSA liquidity shock could halt growth despite favorable law.

Trade implications: Tactical asymmetric trades work best — buy CVX optionality and hedge XOM political/execution risk. If Brent sustains >$75 (30d SMA) or Venezuelan fiscal terms published within 90 days, CVX equity rerating is likelier; absent that, premiums on CVX options will compress. Use pair trades and protective puts rather than naked directional bets given policy tail risk.

Contrarian angles: The market underprices Chevron’s near-term production upside funded internally; conversely, market may overreact to Woods’ “uninvestable” remark and temporarily discount XOM’s Guyana upside if the ICJ rules favorably. Historical parallels: Iran re-entry after sanctions shows rapid capital inflow once legal certainty exists — expect a clustered capex wave, not steady trickle. Unintended consequence: aggressive political rhetoric can delay investment even when legal reforms exist, keeping spreads elevated.

Key Decisions for Investors

• Establish a 2–3% portfolio long position in CVX via a 6–9 month call spread (size cost to ≤2% portfolio); add an incremental 1–2% if Brent 30‑day SMA > $75 for 30 consecutive days or Venezuelan hydrocarbons law is finalized with foreign-investor protections within 90 days.
• Initiate a dollar‑neutral pair trade: long CVX / short XOM at 1:1 notional sized to 1–2% portfolio; take profits if CVX outperforms XOM by >7% or cut at a 5% adverse spread move, horizon 6–12 months to capture Venezuela optionality vs. political premium.
• Buy tail protection: purchase 6‑month XOM 5% OTM puts sized to 0.75–1% portfolio to hedge against sudden policy/expropriation shocks; unwind if implied vol >50% or if the US issues broad licenses permitting Venezuela investment.
• Conditional sector tilt: overweight energy ETF XLE by +2% if Brent 30‑day SMA > $70 for 30 days or if ICJ rules favorably for Guyana within 12 months; otherwise keep energy allocation flat and redeploy to higher-growth sectors.